Cerity Partners’s Amedisys AMED Stock Holding History

Cerity Partners’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,426	Closed	-$731K	–	2744
2025 Q2	$731K	Buy	7,426 +2,432	+49%	+$230K	﹤0.01%	1673
2025 Q1	$463K	Buy	+4,994	New	+$460K	﹤0.01%	1801
2024 Q4	–	Sell	-3,222	Closed	-$311K	–	2425
2024 Q3	$311K	Buy	+3,222	New	+$314K	﹤0.01%	2034
2021 Q3	–	Sell	-909	Closed	-$223K	–	686
2021 Q2	$223K	Buy	909 +146	+19%	+$38.3K	﹤0.01%	657
2021 Q1	$202K	Buy	+763	New	+$215K	﹤0.01%	662

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cerity Partners's AMED Position: Q3 2025 in Review

Cerity Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,426 shares — an estimated $731K sold.

Cerity Partners first reported a position in AMED in Q1 2021 and held it in 5 quarters. The position peaked at $731K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Cerity Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Cerity Partners sold 7,426 Amedisys shares in Q3 2025, an estimated $731K.
Cerity Partners first reported a position in Amedisys in Q1 2021 and held it in 5 quarters.
Cerity Partners's Amedisys position peaked at $731K in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cerity Partners's 13F filing for Q3 2025, filed 22 Oct 2025.